EFFECT OF NEUROLEPTIC WITHDRAWAL ON PLASMA PROLACTIN - A POSSIBLE MARKER OF RECEPTOR ADAPTATION

被引:18
作者
KIRKPATRICK, B [1 ]
BUCHANAN, RW [1 ]
MAEDA, K [1 ]
CARPENTER, WT [1 ]
JAUCH, D [1 ]
TAMMINGA, CA [1 ]
机构
[1] UNIV MARYLAND,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21201
关键词
D O I
10.1016/0006-3223(89)90016-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:131 / 138
页数:8
相关论文
共 22 条
[1]   TOLERANCE TO THE PROLACTIN-ELEVATING EFFECT OF NEUROLEPTICS [J].
BROWN, WA ;
LAUGHREN, TP .
PSYCHIATRY RESEARCH, 1981, 5 (03) :317-322
[2]  
BROWN WA, 1981, AM J PSYCHIAT, V138, P237
[3]   EARLY INTERVENTION, TIME-LIMITED, TARGETED PHARMACOTHERAPY OF SCHIZOPHRENIA [J].
CARPENTER, WT ;
HEINRICHS, DW .
SCHIZOPHRENIA BULLETIN, 1983, 9 (04) :533-542
[4]  
CHOUINARD G, 1980, AM J PSYCHIAT, V137, P16
[5]   POSSIBLE ASSOCIATIONS AMONG PLASMA PROLACTIN LEVELS, TARDIVE-DYSKINESIA, AND PARANOIA IN TREATED MALE-SCHIZOPHRENICS [J].
CSERNANSKY, JG ;
PROSSER, E ;
KAPLAN, J ;
MAHLER, E ;
BERGER, PA ;
HOLLISTER, LE .
BIOLOGICAL PSYCHIATRY, 1986, 21 (07) :632-642
[6]  
DAVIS BM, 1985, ARCH GEN PSYCHIAT, V42, P259
[7]  
DAVIS JM, 1976, ARCH GEN PSYCHIAT, V33, P858
[8]  
FARAONE SV, 1987, J CLIN PSYCHIAT, V48, P151
[9]   NEUROLEPTIC BIOAVAILABILITY, PSYCHOSOCIAL FACTORS, AND CLINICAL STATUS - A 1-YEAR STUDY OF SCHIZOPHRENIC OUTPATIENTS AFTER DOSE REDUCTION [J].
FARAONE, SV ;
CURRAN, JP ;
LAUGHREN, T ;
FALTUS, F ;
JOHNSTON, R ;
BROWN, WA .
PSYCHIATRY RESEARCH, 1986, 19 (04) :311-322
[10]   LOSS OF CENTRAL NERVOUS-SYSTEM COMPONENT OF DOPAMINERGIC INHIBITION OF PROLACTIN SECRETION IN PATIENTS WITH PROLACTIN-SECRETING PITUITARY TUMORS [J].
FINE, SA ;
FROHMAN, LA .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (04) :973-980